TGTX Stock Analysis: Buy, Sell, or Hold?
TGTX - TG Therapeutics, Inc.
$49.52
1.47 (3.06%)
▲
5d:
+23.31%
30d:
+16.11%
90d:
+77.11%
HOLD
MODERATE Confidence
Analysis Updated: Jun 12, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.3/10
Get Alerted When TGTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: TGTX is 12.4% above its trading range ($44.04). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: TGTX is 12.4% above its trading range ($44.04). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$85.02
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$52.79
6.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TGTX is currently trading at $49.52, which is considered extended relative to its 30-day fair value range of $37.63 to $44.04. From a valuation perspective, the stock is trading at a premium (Forward PE: 17.2) compared to its historical average (15.2). At these levels, the market is pricing in 4.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TGTX is in a strong uptrend. The price is approaching resistance at $49.97. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: TGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TGTX is in a strong uptrend. The price is approaching resistance at $49.97. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.1% recently.
Market Sentiment: TGTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$37.63 -
$44.04
Company Quality Score
67/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
53.3%
Protect Your Profits
TGTX is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.4% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.1%)
- NEUTRAL: Near Wall St target ($48.00)
- NEUTRAL: Market pricing in 4.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$37.63 -
$44.04
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$36.48
Resistance Level
$49.97
Current Trend
Strong Uptrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
17.24
Wall Street Target
$48.00
(-3.1%)
Revenue Growth (YoY)
69.6%
Earnings Growth (YoY)
300.0%
Profit Margin
66.0%
Valuation Premium vs History
+4.3% premium
PE vs Historical
17.2 vs 15.2
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.3%
(market-implied from PE analysis)
1-Year Target
$51.65
(+4%)
2-Year Target
$53.87
(+9%)
3-Year Target
$56.19
(+14%)
3-Yr Target (if PE normalizes)
(PE: 17→15)
PE COMPRESSION
$49.53
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 87.1%)
$212.49
(+329%)
Base:
(SPY PE: 17.2, Growth: 87.1%)
$167.13
(+238%)
Bear:
(PE: 14.7, Growth: 87.1%)
$142.06
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 16.80 | Current EPS (TTM): $2.86
Bull Case
$53.08
(+7%)
Analyst growth 0.4%, PE expands to 18.5
Base Case
$48.25
(-3%)
Market implied 0.4%, PE stable at 16.8
Bear Case
$32.67
(-34%)
Severe decline -20.0%, PE contracts to 14.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 15, 2026 4:48 AM ET
Data refreshes hourly during market hours. Next update: 5:48 AM
Data refreshes hourly during market hours. Next update: 5:48 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TGTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 50 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$275 | 61 BUY |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$123 | 54 HOLD |
Advanced TGTX Option Strategies
Professional options setups generated by AI based on today's TGTX price and gamma walls.
